Short answer
ABEONA THERAPEUTICS INC. (ABEO) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Keith A. Goldan and Bernhardt G. Zeiher, M.D. elected Class 1 directors through 2029.
ABEONA THERAPEUTICS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Keith A. Goldan and Bernhardt G. Zeiher, M.D. elected Class 1 directors through 2029
- Executive compensation approved in advisory vote, 23,300,653 votes for versus 4,511,866 against
- Deloitte & Touche LLP ratified as independent auditor for fiscal 2026, with 40,560,995 votes for
- Equity plan capacity increased from 8,400,000 to 11,500,000 shares, expanding potential dilution
- Proposal to remove advance-notice director nomination provision failed, preserving the existing provision
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ABEONA THERAPEUTICS INC. 8-K filings
Get the next ABEO 8-K as it lands
Follow ABEO for push alerts, or ask the research agent what this filing means.